Libor Kolesár

1.3k total citations
30 papers, 602 citations indexed

About

Libor Kolesár is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Libor Kolesár has authored 30 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Libor Kolesár's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Renal Transplantation Outcomes and Treatments (5 papers) and Immune Cell Function and Interaction (5 papers). Libor Kolesár is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Renal Transplantation Outcomes and Treatments (5 papers) and Immune Cell Function and Interaction (5 papers). Libor Kolesár collaborates with scholars based in Czechia, United Kingdom and Netherlands. Libor Kolesár's co-authors include Ilja Střı́ž, Alena Sekerková, Antonij Slavčev, Jan Šulc, Martina Šterclová, J Skibová, Petr Pohunek, Eva Honsová, Martina Vašáková and Yelena Pavlova and has published in prestigious journals such as Clinical Science, Respiratory Medicine and Scandinavian Journal of Immunology.

In The Last Decade

Libor Kolesár

30 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Libor Kolesár Czechia 14 195 167 116 103 78 30 602
Douglas R. Mathern United States 7 324 1.7× 56 0.3× 136 1.2× 68 0.7× 82 1.1× 8 757
E. J. Steenbergen Netherlands 18 137 0.7× 125 0.7× 262 2.3× 115 1.1× 40 0.5× 33 1.0k
Arnaud François France 15 220 1.1× 100 0.6× 180 1.6× 104 1.0× 92 1.2× 68 821
Rana Herro United States 16 267 1.4× 95 0.6× 126 1.1× 96 0.9× 49 0.6× 22 600
Eva Ellinghaus Germany 13 205 1.1× 36 0.2× 176 1.5× 128 1.2× 111 1.4× 17 711
André Zandvoort Netherlands 14 243 1.2× 223 1.3× 151 1.3× 123 1.2× 114 1.5× 20 752
S Nash United States 11 188 1.0× 121 0.7× 231 2.0× 141 1.4× 75 1.0× 15 821
Sarah L. Snelgrove Australia 11 350 1.8× 66 0.4× 169 1.5× 65 0.6× 88 1.1× 17 742
Thomas Savage United States 13 218 1.1× 77 0.5× 119 1.0× 157 1.5× 69 0.9× 24 789
Ruoyun Tan China 15 75 0.4× 106 0.6× 477 4.1× 95 0.9× 65 0.8× 41 879

Countries citing papers authored by Libor Kolesár

Since Specialization
Citations

This map shows the geographic impact of Libor Kolesár's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libor Kolesár with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libor Kolesár more than expected).

Fields of papers citing papers by Libor Kolesár

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Libor Kolesár. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libor Kolesár. The network helps show where Libor Kolesár may publish in the future.

Co-authorship network of co-authors of Libor Kolesár

This figure shows the co-authorship network connecting the top 25 collaborators of Libor Kolesár. A scholar is included among the top collaborators of Libor Kolesár based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Libor Kolesár. Libor Kolesár is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allain, Vincent, Libor Kolesár, Lisa E. Creary, et al.. (2024). Two‐field resolution on‐call HLA typing for deceased donors using nanopore sequencing. HLA. 103(3). e15441–e15441. 7 indexed citations
2.
Trunečka, Pavel, Dana Dlouhá, Jaroslav A. Hubáček, et al.. (2018). Donor PNPLA3 rs738409 genotype is a risk factor for graft steatosis. A post-transplant biopsy-based study. Digestive and Liver Disease. 50(5). 490–495. 24 indexed citations
3.
Cecrdlova, Eva, Kateřina Petřı́čková, Libor Kolesár, et al.. (2015). Manumycin A downregulates release of proinflammatory cytokines from TNF alpha stimulated human monocytes. Immunology Letters. 169. 8–14. 6 indexed citations
4.
Kolesár, Libor, et al.. (2014). Chemokines Induced in Human Respiratory Epithelial Cells by IL-1 Family of Cytokines. Folia Biologica. 60(4). 180–186. 14 indexed citations
5.
Vašáková, Martina, Martina Šterclová, Radoslav Matěj, et al.. (2013). IL-4 polymorphisms, HRCT score and lung tissue markers in idiopathic pulmonary fibrosis. Human Immunology. 74(10). 1346–1351. 12 indexed citations
6.
Pavlova, Yelena, Ondřej Viklický, Janka Slatinská, et al.. (2011). Soluble CD30 and Hepatocyte growth factor as predictive markers of antibody-mediated rejection of the kidney allograft. Transplant Immunology. 25(1). 72–76. 8 indexed citations
7.
Kolesár, Libor, Xiaodong Liu, Irena Brabcová, et al.. (2011). Epithelial cells modulate genes associated with NF kappa B activation in co-cultured human macrophages. Immunobiology. 216(10). 1110–1116. 14 indexed citations
8.
Pavlova, Yelena, I. Málek, Eva Honsová, et al.. (2010). Hepatocyte growth factor and antibodies to HLA and MICA antigens in heart transplant recipients. Tissue Antigens. 76(5). 380–386. 9 indexed citations
9.
Sosna, O, Libor Kolesár, Antonij Slavčev, et al.. (2010). Th1/Th2 Cytokine Gene Polymorphisms in Patients With Uterine Fibroid. Folia Biologica. 56(5). 206–210. 14 indexed citations
10.
Kolesár, Libor, et al.. (2009). CXC and CC chemokines induced in human renal epithelial cells by inflammatory cytokines. Apmis. 117(7). 477–487. 24 indexed citations
11.
Šterclová, Martina, et al.. (2009). Angiostatic versus angiogenic chemokines in IPF and EAA. Respiratory Medicine. 103(11). 1651–1656. 8 indexed citations
12.
Šterclová, Martina, Libor Kolesár, Antonij Slavčev, et al.. (2008). Bronchoalveolar Lavage Fluid Cellular Characteristics, Functional Parameters and Cytokine and Chemokine Levels in Interstitial Lung Diseases. Scandinavian Journal of Immunology. 69(3). 268–274. 54 indexed citations
13.
Vašáková, Martina, Martina Šterclová, Libor Kolesár, et al.. (2008). Cytokine gene polymorphisms and BALF cytokine levels in interstitial lung diseases. Respiratory Medicine. 103(5). 773–779. 21 indexed citations
14.
Pavlova, Yelena, et al.. (2008). Distribution of KIR genes in the Czech population. International Journal of Immunogenetics. 35(1). 57–61. 23 indexed citations
15.
Slavčev, Antonij, et al.. (2007). Correlation of IL‐1alpha and IL‐4 Gene Polymorphisms and Clinical Parameters in Idiopathic Pulmonary Fibrosis. Scandinavian Journal of Immunology. 65(3). 265–270. 17 indexed citations
16.
Kolesár, Libor, et al.. (2007). Cytokine gene polymorphisms in the Dutch population. International Journal of Immunogenetics. 34(2). 87–90. 10 indexed citations
17.
Kolesár, Libor, et al.. (2007). Polymorphism of interleukin‐18 promoter influences the onset of kidney graft function after transplantation. Tissue Antigens. 70(5). 363–368. 18 indexed citations
18.
Vašáková, Martina, et al.. (2006). Cytokine gene polymorphisms and high-resolution-computed tomography score in idiopathic pulmonary fibrosis. Respiratory Medicine. 101(5). 944–950. 9 indexed citations
19.
Slavčev, Antonij, et al.. (2006). Th1/Th2 cytokine gene polymorphisms in patients with idiopathic pulmonary fibrosis. Tissue Antigens. 67(3). 229–232. 33 indexed citations
20.
Novota, Peter, Libor Kolesár, Antonij Slavčev, & Marie Černá. (2004). Fluorescence-Based Automated Fragment Analysis of Microsatellite Polymorphism within the Transmembrane Region of the MIC-A Gene. Folia Biologica. 50(1). 21–23. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Douglas R. Mathern Breakdown of academic impact, for papers by E. J. Steenbergen Breakdown of academic impact, for papers by Arnaud François Breakdown of academic impact, for papers by Rana Herro Breakdown of academic impact, for papers by Eva Ellinghaus Breakdown of academic impact, for papers by André Zandvoort Breakdown of academic impact, for papers by S Nash Breakdown of academic impact, for papers by Sarah L. Snelgrove Breakdown of academic impact, for papers by Thomas Savage Breakdown of academic impact, for papers by Ruoyun Tan
Rankless by CCL
2026